WFSBP 2021 Preliminary Program
WFSBP 2021 8 Preliminary Scientific Program Schedule / Tuesday, 29 June 2021 7:30 S-20 Are anti-inflammatory treatments really useful in depression? S-21 OCD: Enigma wrapped in a riddle S-22 Towards digital-based care of schizophrenia: Where are we heading? S-23 COVID-19 and mental health: What do we know? S-24 The microbiota-gut- brain axis in psychiatric disorders: Gene-environment interactions and therapeutic targets S-25 Treatment and outcome of different clinical facets of Bipolar disorder 8:00 8:30 9:00 9:30 D-02 The Amyloid Hypothe- sis is the key for a cure for Alzheimer’s Disease S-26 Purinergic mechanisms in psychiatric disorders WS-01 Immune system and suicidal behaviour: What do we know? S-27 Psychedelics – a way out of the box? S-28 Pharmacogenomics and personalized medi- cine for antipsychotic and antidepressant medications: are we there yet? ES-02 Understanding and de- signing genetic studies 10:00 10:30 11:00 11:30 Satellite Symposia 12:00 12:30 13:00 13:30 TFS-03 Tools for optimizing pharmacotherapy in psychiatry: Focus on antipsychotics TFS-04 Psychopathology in times of precision psychiatry S-29 Nature and nurture in suicidal behaviour: latest updates S-30 Update on the WFSBP guidelines for the Phar- macological Treatment of Eating Disorders S-31 Can translational research enhance the efficacy of rTMS in MDD? ES-03 Machine learning approaches for biological psychiatry 14:00 14:30 15:00 15:30 Plenary Lecture PL-02 Interpersonal psychotherapy – A global reach (Myrna Weissman, USA) 16:00 16:30 17:00 S-32 ENIGMA and the PGC: Large-scale studies of psychiatric genetics and brain imaging TFS-05 Identification of neuro- progressive profiles and course in recurrent affective disorders Part 2 WS-02 Next-step treatment considerations in patients with treatment- resistant depression that respond to low-dose intravenous ketamine S-33 Canadian Network for Mood and Anxiety treatments (CANMAT): update of novel treat- ments and approaches for Bipolar Disorder S-34 Precision psychiatry: The case of treatment resistant schizophrenia S-35 Clearing the smoke: Cannabis, Mood Disorders and Schizo- phrenia. A CANMAT Symposium 17:30 18:00 18:30 19:00 Satellite Symposia 19:30 20:00 20:30 21:00 21:00–23:00 a WFSBP General Assembly All sessions run in Central European Summer Time (CEST). Virtual Posters accessible all day
Made with FlippingBook
RkJQdWJsaXNoZXIy Mzg2Mjgy